CHRISTOPHER J COUGHLIN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CHRISTOPHER J COUGHLIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHRISTOPHER J COUGHLIN. CHRISTOPHER J COUGHLIN is Director in HOLOGIC INC ($HOLX) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and Director in DUN & BRADSTREET CORP/NW ($DNB) and Director in Prestige Consumer Healthcare Inc. ($PBH) and Director in Allergan plc ($AGN) and in Karuna Therapeutics, Inc. ($KRTX).
Latest Insider Trading Transactions of CHRISTOPHER J COUGHLIN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALXN, AGN, DNB, HOLX, KRTX, PBH
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 06 2020 | PBH | Prestige Consumer ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 0.00 | 3,732 | 0 | 7,915 | 4.2 K to 7.9 K (+89.22 %) |
May 18 2020 | ALXN | ALEXION PHARMACEUT ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 0.00 | 2,774 | 0 | 39,656 | 36.9 K to 39.7 K (+7.52 %) |
May 18 2020 | ALXN | ALEXION PHARMACEUT ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 0.00 | 3,468 | 0 | 36,882 | 33.4 K to 36.9 K (+10.38 %) |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Option Exercise | D | 70.79 | 9,446 | 668,682 | 0 | |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Option Exercise | D | 70.79 | 9,446 | 668,682 | 0 | |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Option Exercise | D | 73.14 | 3,691 | 269,960 | 0 | |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Option Exercise | D | 73.14 | 3,691 | 269,960 | 0 | |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Option Exercise | D | 90.22 | 2,790 | 251,714 | 0 | |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Option Exercise | D | 90.22 | 2,790 | 251,714 | 0 | |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Sell | D | 0.00 | 16,532 | 0 | 0 | 16.5 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Sell | D | 0.00 | 16,532 | 0 | 0 | 16.5 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Sell | D | 0.00 | 9,538 | 0 | 16,542 | 26.1 K to 16.5 K (-36.57 %) |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Sell | D | 0.00 | 9,538 | 0 | 16,542 | 26.1 K to 16.5 K (-36.57 %) |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Sell | D | 0.00 | 471 | 0 | 26,080 | 26.6 K to 26.1 K (-1.77 %) |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Sell | D | 0.00 | 471 | 0 | 26,080 | 26.6 K to 26.1 K (-1.77 %) |
May 04 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Payment of Exercise | F | 189.74 | 991 | 188,032 | 16,542 | 17.5 K to 16.5 K (-5.65 %) |
Apr 28 2020 | KRTX | Karuna Therapeutic ... | COUGHLIN CHRISTOPHER J | Option Exercise | A | 86.65 | 25,000 | 2,166,250 | 25,000 | ||
Aug 01 2019 | PBH | Prestige Consumer ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 0.00 | 4,183 | 0 | 4,183 | 0 to 4.2 K |
May 17 2019 | ALXN | ALEXION PHARMACEUT ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 0.00 | 2,181 | 0 | 33,414 | 31.2 K to 33.4 K (+6.98 %) |
May 17 2019 | ALXN | ALEXION PHARMACEUT ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 0.00 | 2,726 | 0 | 31,233 | 28.5 K to 31.2 K (+9.56 %) |
May 02 2019 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Grant | A | 145.33 | 2,064 | 299,961 | 17,080 | 15 K to 17.1 K (+13.75 %) |
May 02 2019 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Payment of Exercise | F | 147.00 | 953 | 140,091 | 15,016 | 16 K to 15 K (-5.97 %) |
Sep 07 2018 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Buy | P | 190.63 | 300 | 57,189 | 16,431 | 16.1 K to 16.4 K (+1.86 %) |
Sep 07 2018 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Buy | P | 190.64 | 517 | 98,561 | 16,131 | 15.6 K to 16.1 K (+3.31 %) |
Sep 07 2018 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Buy | P | 190.68 | 4,889 | 932,235 | 15,614 | 10.7 K to 15.6 K (+45.59 %) |
Sep 07 2018 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Buy | P | 190.67 | 222 | 42,329 | 10,725 | 10.5 K to 10.7 K (+2.11 %) |
Sep 07 2018 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Buy | P | 190.66 | 816 | 155,579 | 10,503 | 9.7 K to 10.5 K (+8.42 %) |
Sep 07 2018 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Buy | P | 190.65 | 100 | 19,065 | 9,687 | 9.6 K to 9.7 K (+1.04 %) |
Sep 07 2018 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Buy | P | 190.62 | 68 | 12,962 | 9,587 | 9.5 K to 9.6 K (+0.71 %) |
Sep 07 2018 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Buy | P | 190.61 | 200 | 38,122 | 9,519 | 9.3 K to 9.5 K (+2.15 %) |
Sep 07 2018 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Buy | P | 190.60 | 400 | 76,240 | 9,319 | 8.9 K to 9.3 K (+4.48 %) |
Sep 07 2018 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Buy | P | 190.59 | 356 | 67,850 | 8,919 | 8.6 K to 8.9 K (+4.16 %) |
Sep 07 2018 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Buy | P | 190.58 | 100 | 19,058 | 8,563 | 8.5 K to 8.6 K (+1.18 %) |
Sep 07 2018 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Buy | P | 190.57 | 27 | 5,145 | 8,463 | 8.4 K to 8.5 K (+0.32 %) |
Sep 07 2018 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Buy | P | 190.56 | 705 | 134,345 | 8,436 | 7.7 K to 8.4 K (+9.12 %) |
Sep 07 2018 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Buy | P | 190.55 | 1,300 | 247,715 | 7,731 | 6.4 K to 7.7 K (+20.21 %) |
May 11 2018 | ALXN | ALEXION PHARMACEUT ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 0.00 | 2,174 | 0 | 28,507 | 26.3 K to 28.5 K (+8.26 %) |
May 04 2018 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Grant | A | 151.07 | 1,985 | 299,874 | 6,431 | 4.4 K to 6.4 K (+44.65 %) |
May 04 2018 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Gift | G | 0.00 | 10,000 | 0 | 4,446 | 14.4 K to 4.4 K (-69.22 %) |
May 02 2018 | ALXN | ALEXION PHARMACEUT ... | COUGHLIN CHRISTOPHER J | Director | Buy | P | 120.79 | 10,000 | 1,207,900 | 26,333 | 16.3 K to 26.3 K (+61.23 %) |
Dec 05 2017 | ALXN | ALEXION PHARMACEUT ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 112.75 | 10,000 | 1,127,500 | 16,333 | 6.3 K to 16.3 K (+157.90 %) |
Dec 05 2017 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Buy | P | 163.30 | 10,000 | 1,633,000 | 14,446 | 4.4 K to 14.4 K (+224.92 %) |
Jun 16 2017 | ALXN | ALEXION PHARMACEUT ... | COUGHLIN CHRISTOPHER J | Director | Buy | P | 117.10 | 2,000 | 234,200 | 6,333 | 4.3 K to 6.3 K (+46.16 %) |
May 12 2017 | ALXN | ALEXION PHARMACEUT ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 0.00 | 2,030 | 0 | 4,333 | 2.3 K to 4.3 K (+88.15 %) |
May 05 2017 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Grant | A | 245.25 | 1,223 | 299,941 | 4,446 | 3.2 K to 4.4 K (+37.95 %) |
May 05 2017 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Payment of Exercise | F | 243.76 | 668 | 162,832 | 3,223 | 3.9 K to 3.2 K (-17.17 %) |
Mar 13 2017 | DNB | DUN & BRADSTREET C ... | COUGHLIN CHRISTOPHER J | Director | Option Exercise | A | 0.00 | 175 | 0 | 38,317 | |
Mar 13 2017 | DNB | DUN & BRADSTREET C ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 107.81 | 75 | 8,086 | 16,536 | 16.5 K to 16.5 K (+0.46 %) |
Mar 09 2017 | HOLX | HOLOGIC INC | COUGHLIN CHRISTOPHER J | Director | Option Exercise | A | 41.92 | 6,816 | 285,727 | 6,816 | |
Mar 09 2017 | HOLX | HOLOGIC INC | COUGHLIN CHRISTOPHER J | Director | Option Exercise | M | 0.00 | 2,427 | 0 | 0 | |
Mar 09 2017 | HOLX | HOLOGIC INC | COUGHLIN CHRISTOPHER J | Director | Grant | A | 0.00 | 2,206 | 0 | 7,633 | 5.4 K to 7.6 K (+40.65 %) |
Mar 09 2017 | HOLX | HOLOGIC INC | COUGHLIN CHRISTOPHER J | Director | Buy | M | 0.00 | 2,427 | 0 | 5,427 | 3 K to 5.4 K (+80.90 %) |
Feb 02 2017 | DNB | DUN & BRADSTREET C ... | COUGHLIN CHRISTOPHER J | Director | Option Exercise | A | 0.00 | 728 | 0 | 38,142 | |
Jan 27 2017 | DNB | DUN & BRADSTREET C ... | COUGHLIN CHRISTOPHER J | Director | Option Exercise | M | 88.04 | 2,086 | 183,651 | 0 | |
Jan 27 2017 | DNB | DUN & BRADSTREET C ... | COUGHLIN CHRISTOPHER J | Director | Buy | M | 88.04 | 2,086 | 183,651 | 18,547 | 16.5 K to 18.5 K (+12.67 %) |
Dec 13 2016 | DNB | DUN & BRADSTREET C ... | COUGHLIN CHRISTOPHER J | Director | Option Exercise | A | 0.00 | 144 | 0 | 37,414 | |
Dec 13 2016 | DNB | DUN & BRADSTREET C ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 122.96 | 63 | 7,746 | 16,461 | 16.4 K to 16.5 K (+0.38 %) |
Sep 13 2016 | DNB | DUN & BRADSTREET C ... | COUGHLIN CHRISTOPHER J | Director | Option Exercise | A | 0.00 | 133 | 0 | 37,270 | |
Sep 13 2016 | DNB | DUN & BRADSTREET C ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 134.56 | 57 | 7,670 | 16,399 | 16.3 K to 16.4 K (+0.35 %) |
Aug 17 2016 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Payment of Exercise | F | 254.05 | 100 | 25,405 | 3,891 | 4 K to 3.9 K (-2.51 %) |
Aug 17 2016 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Payment of Exercise | F | 254.05 | 100 | 25,405 | 3,891 | 4 K to 3.9 K (-2.51 %) |
Aug 09 2016 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Grant | A | 248.31 | 201 | 49,910 | 3,991 | 3.8 K to 4 K (+5.30 %) |
Jul 05 2016 | DNB | DUN & BRADSTREET C ... | COUGHLIN CHRISTOPHER J | Director | Option Exercise | A | 0.00 | 2,300 | 0 | 37,137 | |
Jun 14 2016 | DNB | DUN & BRADSTRE ... | COUGHLIN CHRISTOPHER J | Director | Option Exercise | A | 0.00 | 131 | 0 | 34,838 | |
Jun 14 2016 | DNB | DUN & BRADSTRE ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 126.04 | 61 | 7,688 | 16,342 | 16.3 K to 16.3 K (+0.37 %) |
May 13 2016 | ALXN | ALEXION PHARMACEUT ... | COUGHLIN CHRISTOPHER J | Director | Option Exercise | A | 138.86 | 2,294 | 318,545 | 2,294 | |
May 13 2016 | ALXN | ALEXION PHARMACEUT ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 0.00 | 835 | 0 | 2,303 | 1.5 K to 2.3 K (+56.88 %) |
May 09 2016 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Grant | A | 210.34 | 1,188 | 249,884 | 3,790 | 2.6 K to 3.8 K (+45.66 %) |
May 06 2016 | DNB | DUN & BRADSTRE ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 0.00 | 1,087 | 0 | 16,281 | 15.2 K to 16.3 K (+7.15 %) |
Mar 04 2016 | HOLX | HOLOGIC INC | COUGHLIN CHRISTOPHER J | Director | Option Exercise | A | 0.00 | 2,427 | 0 | 2,427 | |
Mar 04 2016 | HOLX | HOLOGIC INC | COUGHLIN CHRISTOPHER J | Director | Option Exercise | A | 36.04 | 7,402 | 266,768 | 7,402 | |
Mar 15 2016 | DNB | DUN & BRADSTRE ... | COUGHLIN CHRISTOPHER J | Director | Option Exercise | A | 0.00 | 164 | 0 | 34,706 | |
Mar 15 2016 | DNB | DUN & BRADSTRE ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 98.98 | 72 | 7,126 | 15,194 | 15.1 K to 15.2 K (+0.48 %) |
Feb 02 2016 | DNB | DUN & BRADSTRE ... | COUGHLIN CHRISTOPHER J | Director | Option Exercise | A | 0.00 | 2,837 | 0 | 34,542 | |
Dec 15 2015 | DNB | DUN & BRADSTRE ... | COUGHLIN CHRISTOPHER J | Director | Option Exercise | A | 0.00 | 140 | 0 | 31,705 | |
Dec 15 2015 | DNB | DUN & BRADSTRE ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 103.68 | 65 | 6,739 | 15,122 | 15.1 K to 15.1 K (+0.43 %) |
Nov 10 2015 | DNB | DUN & BRADSTRE ... | COUGHLIN CHRISTOPHER J | Director | Option Exercise | M | 71.28 | 2,330 | 166,071 | 0 | |
Nov 10 2015 | DNB | DUN & BRADSTRE ... | COUGHLIN CHRISTOPHER J | Director | Sell | S | 112.50 | 2,330 | 262,134 | 15,057 | 17.4 K to 15.1 K (-13.40 %) |
Nov 10 2015 | DNB | DUN & BRADSTRE ... | COUGHLIN CHRISTOPHER J | Director | Buy | M | 71.28 | 2,330 | 166,071 | 17,387 | 15.1 K to 17.4 K (+15.47 %) |
Sep 15 2015 | DNB | DUN & BRADSTRE ... | COUGHLIN CHRISTOPHER J | Director | Option Exercise | A | 0.00 | 136 | 0 | 31,566 | |
Sep 15 2015 | DNB | DUN & BRADSTRE ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 104.56 | 64 | 6,692 | 15,057 | 15 K to 15.1 K (+0.43 %) |
Aug 25 2015 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Payment of Exercise | F | 298.57 | 124 | 37,023 | 2,602 | 2.7 K to 2.6 K (-4.55 %) |
Aug 18 2015 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Payment of Exercise | F | 314.50 | 100 | 31,450 | 2,726 | 2.8 K to 2.7 K (-3.54 %) |
Jul 01 2015 | DNB | DUN & BRADSTRE ... | COUGHLIN CHRISTOPHER J | Director | Option Exercise | A | 0.00 | 2,296 | 0 | 31,429 | |
Jun 16 2015 | DNB | DUN & BRADSTRE ... | COUGHLIN CHRISTOPHER J | Director | Option Exercise | A | 0.00 | 102 | 0 | 29,134 | |
Jun 16 2015 | DNB | DUN & BRADSTRE ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 129.73 | 52 | 6,746 | 14,993 | 14.9 K to 15 K (+0.35 %) |
Jun 08 2015 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Grant | A | 302.30 | 826 | 249,700 | 2,826 | 2 K to 2.8 K (+41.30 %) |
Jun 08 2015 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Payment of Exercise | F | 303.38 | 334 | 101,329 | 2,000 | 2.3 K to 2 K (-14.31 %) |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | COUGHLIN CHRISTOPHER J | Director | Option Exercise | A | 155.01 | 2,343 | 363,188 | 2,343 | |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 0.00 | 700 | 0 | 1,468 | 768 to 1.5 K (+91.15 %) |
May 08 2015 | DNB | DUN & BRADSTRE ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 0.00 | 954 | 0 | 14,941 | 14 K to 14.9 K (+6.82 %) |
Mar 13 2015 | DNB | DUN & BRADSTRE ... | COUGHLIN CHRISTOPHER J | Director | Option Exercise | A | 0.00 | 104 | 0 | 29,031 | |
Mar 13 2015 | DNB | DUN & BRADSTRE ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 127.21 | 49 | 6,233 | 13,987 | 13.9 K to 14 K (+0.35 %) |
Page: 1